The Australian market has shown resilience, with the ASX200 lifting slightly after an unexpected rise in inflation driven by increased electricity and housing costs. In such a fluctuating environment, investors often look for opportunities beyond the big names, and penny stocks—though an older term—still represent a viable investment area. These smaller or newer companies can offer surprising potential for growth at lower price points when they possess strong balance sheets and solid fundamentals.
Top 10 Penny Stocks In Australia
Name | Share Price | Market Cap | Rewards & Risks |
Alfabs Australia (ASX:AAL) | A$0.44 | A$126.1M | ✅ 4 ⚠️ 3 View Analysis > |
EZZ Life Science Holdings (ASX:EZZ) | A$2.47 | A$116.52M | ✅ 4 ⚠️ 2 View Analysis > |
IVE Group (ASX:IGL) | A$2.75 | A$424M | ✅ 4 ⚠️ 2 View Analysis > |
Veris (ASX:VRS) | A$0.071 | A$36.76M | ✅ 4 ⚠️ 2 View Analysis > |
SHAPE Australia (ASX:SHA) | A$4.18 | A$344.2M | ✅ 3 ⚠️ 1 View Analysis > |
West African Resources (ASX:WAF) | A$3.04 | A$3.47B | ✅ 4 ⚠️ 1 View Analysis > |
Bravura Solutions (ASX:BVS) | A$2.27 | A$1.02B | ✅ 3 ⚠️ 3 View Analysis > |
Praemium (ASX:PPS) | A$0.735 | A$351.48M | ✅ 5 ⚠️ 2 View Analysis > |
MaxiPARTS (ASX:MXI) | A$2.46 | A$136.39M | ✅ 3 ⚠️ 2 View Analysis > |
CTI Logistics (ASX:CLX) | A$1.865 | A$150.22M | ✅ 4 ⚠️ 2 View Analysis > |
Click here to see the full list of 444 stocks from our ASX Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Aurelia Metals (ASX:AMI)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Aurelia Metals Limited is an Australian company focused on the exploration and production of mineral properties, with a market capitalization of A$372.37 million.
Operations: Aurelia Metals generates revenue from its mineral operations primarily through the Peak Mine at A$290.14 million, followed by the Hera Mine at A$31.32 million and the Dargues Mine at A$22.01 million.
Market Cap: A$372.37M
Aurelia Metals has shown promising financial progress, reporting A$343.47 million in sales for the fiscal year ending June 2025, a rise from A$309.89 million the previous year, and achieving profitability with a net income of A$48.85 million compared to last year's loss. The company trades at a significant discount to its estimated fair value and maintains stable weekly volatility. Its short-term assets exceed both short-term and long-term liabilities, while its debt is well-covered by operating cash flow and interest payments by EBIT. Despite an inexperienced board, Aurelia's management team is seasoned with an average tenure of 2.2 years.
- Unlock comprehensive insights into our analysis of Aurelia Metals stock in this financial health report.
- Gain insights into Aurelia Metals' future direction by reviewing our growth report.
Brazilian Rare Earths (ASX:BRE)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Brazilian Rare Earths Limited is engaged in the exploration of rare earth elements and other critical minerals in Brazil, with a market cap of A$533.95 million.
Operations: No specific revenue segments have been reported for this company.
Market Cap: A$533.95M
Brazilian Rare Earths Limited, with a market cap of A$533.95 million, remains pre-revenue and unprofitable but is debt-free and has sufficient cash runway for over a year. Recent developments highlight significant progress in its Monte Alto Project, where the company successfully produced high-purity mixed-rare earth carbonate (MREC) and uranium peroxide. These advancements are crucial steps toward establishing an integrated supply chain for rare-earths in Brazil. Additionally, exploration at the Sulista Project revealed ultra-high-grade deposits and promising drill results, indicating potential for substantial resource expansion across multiple targets within the region.
- Click here to discover the nuances of Brazilian Rare Earths with our detailed analytical financial health report.
- Assess Brazilian Rare Earths' future earnings estimates with our detailed growth reports.
BrainChip Holdings (ASX:BRN)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: BrainChip Holdings Ltd specializes in developing software and hardware accelerated solutions for artificial intelligence and machine learning applications across various regions, with a market cap of A$427.51 million.
Operations: The company generates revenue from the Technological Development of Designs, amounting to $1.31 million.
Market Cap: A$427.51M
BrainChip Holdings Ltd, with a market cap of A$427.51 million, remains unprofitable and is considered pre-revenue with sales of US$1.02 million for the recent half-year. Despite this, its innovative Akida technology positions it as a potential disruptor in AI applications, notably through the launch of the BrainChip Developer Akida Cloud which facilitates rapid prototyping without physical hardware. The company is debt-free but faces challenges with less than a year of cash runway if current cash flow trends persist. Strategic collaborations aim to enhance power efficiency in IoT markets, yet profitability remains elusive in the near term.
- Click to explore a detailed breakdown of our findings in BrainChip Holdings' financial health report.
- Examine BrainChip Holdings' earnings growth report to understand how analysts expect it to perform.
Summing It All Up
- Jump into our full catalog of 444 ASX Penny Stocks here.
- Searching for a Fresh Perspective? The latest GPUs need a type of rare earth metal called Terbium and there are only 27 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if BrainChip Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:BRN
BrainChip Holdings
Develops software and hardware accelerated solutions for artificial intelligence and machine learning applications in North America, Oceania, Europe, the Middle East, and Asia.
Adequate balance sheet with slight risk.
Market Insights
Community Narratives


